of 54°C, and 45 amplifi cation cycles. PCR blanks containing all reagents except for DNA and extraction blanks were included in every PCR set.
Results of the amplifi cation reactions are listed in the Table. All accompanied extraction and PCR controls remained free of amplifi cation products. All amplicons resulting from suicide PCRs were sequenced. Amplicons resulting from the use of primer pairs YP14F/YP13R and pst-F/pst-R matched the reference sequence to 100% (GenBank accession no. AL109969.1). Amplicons resulting from the use of primer pair PCP-F/PCP-R matched this reference sequence to only 97.78%. This deviation is because of a 2-bp insertion (2 Ts, positions 8531 and 8532, GenBank accession no. AL109969.1) at Y. pestis strain CO92 plasmid pPCP1. The sequences obtained from 3 persons' remains showed in the pPCP1 sequence section between nucleotide positions 8528-8532 only 3 Ts instead of 5 Ts described for Y. pestis strain CO92 plasmid pPCP1 (GenBank accession no. AL109969.1). The sequences found in this study were deposited in GenBank under accession nos. HQ290521-HQ290523.
To conclude, the successful recovery of several Y. pestis plasmid pPCP1 DNA sequences in skeletal fi nds from the mass burial site excavated in Manching-Pichl suggests that these persons died of plague. Moreover, our fi ndings constitute a molecularly supported confi rmation for the presence of Y. pestis, the etiologic agent of plague, in late medieval (1250-1500 CE) southern Germany. In future studies, we will attempt to recover chromosomal Y. pestis DNA from the mass grave skeletal remains to obtain clues as to the specifi c Y. pestis strain and the microbiology of past plague in Europe. (2) . Of these 54 cases, 19 (35%) were in men who have sex with men (MSM), 5 (9%) were in injection drug users (IDU), and 2 (4%) were in those in both categories.
Ingrid
In March 2008, a cluster of newly identifi ed HIV-1 infections that included 5 cases (cluster A) in a rural southeastern Idaho city (city A) was reported to the Idaho Department of Health and Welfare. Two patients were men and the median age was 26 years (range 18-32 years). One patient was an IDU (Table) . Through epidemiologic investigation, 3 additional patients were suspected to be IDUs, but confi rmation was not practicable. All reported methamphetamine use. One man and 2 women reported both male and female sex partners.
During September-December of that year, another increase in newly identifi ed HIV-1 infections in southeastern Idaho (cluster B) was reported to Idaho Department of Health and Welfare. Cluster B included 10 cases, all among men who reported living within a 50-mile radius of city A, with most in a rural city (city B
Although the primary use of HIV-1 sequence data is to assist clinicians in selecting antiretroviral (ARV) therapy, public health practitioners can use HIV-1 sequences from cases and compare those with HIV-1 sequences from others living in the region to explore phylogenetic associations and possible HIV transmission clusters (3). To evaluate links between clusters A and B, HIV-1 pol consensus sequence data for 4 of the 5 cases from cluster A and 6 of the 10 cases from cluster B were obtained from 5 commercial laboratories. No case-patients had received ARV. Additionally, we used sequence data from a patient residing in city B who had received an HIV-1 diagnosis in December 2008 but was not epidemiologically linked to either cluster. HIV-1 control sequences from 2 Idaho HIV clinics, including 34 HIV-1-infected persons within a 275-mile radius of city B identifi ed who had not received ARV and who had resistance testing performed during 2005-2008, were used to represent the regional epidemic. Control sequences were aligned with cluster A and B sequences and analyzed as described (4, 5) .
Ten of the HIV case-patients for whom nucleotide sequence data were obtained were infected with HIV-1, subtype B, and were placed into 2 distinct phylogenetic-related groupings. Group 1 contained 4 patients from cluster A and 1 patient with no known epidemiologic link to either cluster. Group 2 contained 5 patients from cluster B. The average pol genetic distance among virus from members of group 1 was 0.2% (median 0.1%, SD 0.2%) and from members of group 2 was 0.1% (median 0.1%, SD 0.1%). The average distance among the control sequences was 5.1% (median 5.2%, SD 1.2%). The average distance between groups 1 and 2 was 4.8% (median 4.8%, SD 0.2%), which does not demonstrate a linkage between the 2 groups. The 1 case in group 1 that was not initially identifi ed with either cluster had a genetically related HIV-1 sequence to members of cluster A, indicating a potential previously unidentifi ed epidemiologic link. The sequence from 1 case associated with cluster B was not genetically similar to members of either cluster and was more similar to controls. These data do not indicate from whom each patient acquired the infection.
The epidemiologic investigation combined with the molecular analysis shows transmission of HIV-1 originating from 2 sources occurred within a group of rural MSM in southeastern Idaho and indicates a separate case previously believed to be unrelated to 2 local clusters had genetic similarity to cluster A. Limitations of this investigation include the inability to obtain HIV sequences from all persons identifi ed in clusters A and B and an inability to confi rm high-risk behaviors for all identifi ed case-patients.
Previous HIV clusters have demonstrated that infectious persons can spread HIV quickly within a social network and highlighted the importance of timely prevention activities to limit HIV transmission in a community (6,7). Use of phylogenetic analysis of HIV-1 sequences obtained from commercial laboratories showed that clusters A and B were not epidemiologically related and helped target appropriate and specifi c HIV prevention activities. (1), fever was the most common feature, followed by progressive dyspnea and intermittent cough. None of our patients reported sore throat. Moreover, such nonspecifi c symptoms may be inadvertently attributed to concurrent medical problems common in immu-
